Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa

BACKGROUND: Updated World Health Organization (WHO) treatment guidelines prioritize all-oral drug-resistant tuberculosis (DR-TB) regimens. Several poorly tolerated drugs, such as amikacin and para-aminosalicylic acid (PAS), remain treatment options for DR-TB in WHO-recommended longer regimens as Gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietersen, Elize, Anderson, Kim, Cox, Helen, Dheda, Keertan, Bian, Aihua, Shepherd, Bryan E., Sterling, Timothy R., Warren, Robin M., van der Heijden, Yuri F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925007/
https://www.ncbi.nlm.nih.gov/pubmed/36780443
http://dx.doi.org/10.1371/journal.pone.0281097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925007/
https://www.ncbi.nlm.nih.gov/pubmed/36780443
http://dx.doi.org/10.1371/journal.pone.0281097

Ejemplares similares